Jeffrey Stein Cidara Therapeutics, Inc. (CDTX) insider trading activity

Jeffrey Stein is President & CEO of Cidara Therapeutics, Inc.. Currently has a direct ownership of 0 shares of CDTX, which is worth approximately $0. The most recent transaction as insider was on Jan 07, 2026, when has been sold 5,763 shares (Common Stock) at a price of $221.5 per share, resulting in proceeds of $1,276,504. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

100.0% 3M change

100.0% 12M change

Total Value Held $0

Jeffrey Stein Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 07 2026	SELL Sale (or disposition) back to the issuer	$1,276,504 $221.5 p/Share	5,763 Reduced 100.0%	0 Common Stock
Dec 19 2025	SELL Bona fide gift	-	10,638 Reduced 50.82%	10,295 Common Stock
Dec 17 2025	SELL Bona fide gift	-	2,244 Reduced 9.7%	20,883 Common Stock
Dec 10 2025	SELL Bona fide gift	-	33,072 Reduced 58.85%	23,127 Common Stock
Dec 10 2025	SELL Payment of exercise price or tax liability	$501,786 $219.6 p/Share	2,285 Reduced 3.91%	56,199 Common Stock
Mar 11 2024	SELL Payment of exercise price or tax liability	$39,117 $0.69 p/Share	56,692 Reduced 4.68%	1,153,693 Common Stock
Mar 27 2023	BUY Grant, award, or other acquisition	-	271,750 Added 18.43%	1,202,385 Common Stock

Mar 31 2022	SELL Payment of exercise price or tax liability	$117,018 $0.83 p/Share	140,985 Reduced 13.26%	922,635 Common Stock
Mar 31 2022	BUY Grant, award, or other acquisition	-	573,742 Added 35.04%	1,063,620 Common Stock
Dec 29 2021	BUY Exercise of conversion of derivative security	-	20,000 Added 3.92%	489,878 Common Stock
Nov 12 2021	BUY Open market or private purchase	$79,500 $1.59 p/Share	50,000 Added 9.69%	465,878 Common Stock
Aug 19 2021	BUY Open market or private purchase	$17,900 $1.79 p/Share	10,000 Added 2.35%	415,878 Common Stock
Aug 18 2021	BUY Open market or private purchase	$68,800 $1.72 p/Share	40,000 Added 8.97%	405,878 Common Stock
Mar 31 2021	BUY Grant, award, or other acquisition	-	10,000 Added 2.69%	361,878 Common Stock
Nov 10 2020	SELL Other acquisition or disposition	$100,025 $40.01 p/Share	2,500 Reduced 30.26%	5,763 Common Stock
Nov 10 2020	BUY Open market or private purchase	$100,000 $2.0 p/Share	50,000 Added 12.57%	347,878 Common Stock
Sep 12 2017	SELL Other acquisition or disposition	$49,838 $135.8 p/Share	367 Reduced 4.25%	8,263 Common Stock
Jun 05 2017	SELL Other acquisition or disposition	$89,212 $118.95 p/Share	750 Reduced 8.0%	8,630 Common Stock
Mar 31 2017	SELL Other acquisition or disposition	$99,975 $155.0 p/Share	645 Reduced 6.43%	9,380 Common Stock
May 23 2016	SELL Other acquisition or disposition	-	270 Reduced 2.62%	10,025 Common Stock

Also insider at

IDYA

IDEAYA Biosciences, Inc. Healthcare

PRTK

Paratek Pharmaceuticals, Inc. Healthcare

Director

Jeffrey Stein

President & CEO

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CDTX shares.

Notify only if

Value

Insider Trading

Get notified when an Cidara Therapeutics, Inc. insider buys or sells CDTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Cidara Therapeutics, Inc.

Track Activities on CDTX

Account